Atlas Trials

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Clinical trial NCT03100877 · WITHDRAWN

Trial details

NCT number
NCT03100877
Sponsor
City of Hope Medical Center
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Plasma Cell Leukemia in RemissionPlasma Cell Myeloma
Start date
2018-01-01
Primary completion
2020-05-24
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.